Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 21-24

  Terashi, Kenji ^a   Oka, Mikio ^a   Ohdo, Shigehiro ^b   Furukubo, Taku ^b   Ikeda, Chizuko ^b   Fukuda, Minoru ^a   Soda, Hiroshi ^a   Higuchi, Shun ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOTINYLATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; NEUTROPHIL; NEUTROPHILIA; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0032906946     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.21     Document Type: Article

References (20)

1. Akizawa, T., K. Shishido, and S. Koshikawa. 1995. The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure. Artif. Organs 19:1251-1257.
2. Avalos, B. R. 1996. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88:761-777.
3. Hoelzer, D. 1997. Hematopoietic growth factors - not whether, but when and where. N. Engl. J. Med. 336:1822-1824.
4. Kiriyama, R., K. Chichibu, T. Matsuno, and N. Ohsawa. 1993. Sensitive chemiluminescent immunoassay for human granulocyte colony-stimulating factor (G-CSF) in clinical applications. Clin. Chim. Acta 220:201-209.
5. Laricchia-Robbio, L., S. Moscato, A. Genua, A. M. Liberati, and R. P. Revoltella. 1997. Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum. J. Cell. Physiol. 173:219-226.
6. Layton, J. E., H. Hockman, W. P. Sheridan, and G. Morstyn. 1989. Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood 74:1303-1307.
7. Matsuzaki, G., X.-Y. Li, Y. Ohyama, and K. Nomoto. 1996. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice. Int. J. Immunopharmacol. 18:363-369.
8. Nicola, N. A., L. Peterson, D. J. Hilton, and D. Metcalf. 1988. Cellular processing of murine colony-stimulating factor (multi-CSF, GM-CSF, G-CSF) receptors by normal hemopoietic cells and cell lines. Growth Factor 1: 41-49.
9. Piscitelli, S. C., W. G. Reiss, W. D. Figg, and W. Petros. 1997. Pharmacokinetics studies with recombinant cytokines: scientific issues and practical considerations. Clin. Pharmacokinet. 32:368-381.
10. Shimoda, K., S. Okamura, N. Harada, and Y. Niho. 1992. Detection of the granulocyte colony-stimulating factor receptor using biotinylated granulocyte colony-stimulating factor: presence of granulocyte colony-stimulating factor receptor on CD34-positive hematopoietic progenitor cells. Res. Exp. Med. 192:245-255.
11. Shinjo, K., A. Takeshita, K. Ohnishi, and R. Ohno. 1995. Expression of granulocyte colony-stimulating factor receptor increases with differentiation in myeloid cells by a newly-devised quantitative flow-cytometric assay. Br. J. Haematol. 91:783-794.
12. Steinman, R. A., and D. J. Tweardy. 1994. Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood 83:119-127.
13. Stute, N., V. M. Santana, J. H. Rodman, M. J. Schell, J. N. Ihle, and W. E. Evans. 1992. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood 79:2849-2854.
14. Takatani, H., H. Soda, M. Fukuda, M. Watanabe, A. Kinoshita, T. Nakamura, and M Oka. 1996. Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts. Antimicrob. Agents Chemother. 40:988-991.
15. Tanaka, H., and T. Tokiwa. 1990. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat. Cancer Res. 50:6615-6619.
16. Tatsumi, N., T. Yamane, I. Tsuda, K. Okuda, and W. Chaisiripoomkere. 1993. Flow cytometric detection of recombinant human granulocyte-colony stimulating factor binding to leukemic cells. J. Clin. Lab. Anal. 7:86-90.
17. Tsuruta, T., K. Tani, M. Shimane, K. Ozawa, S. Takahashi, D. Tsuchimoto, K. Takahashi, S. Nagata, N. Sato, and S. Asano. 1996. Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders. Br. J. Haematol. 92: 9-22.
18. Watari, K., K. Ozawa, S. Takahashi, A. Tojo, K. Tani, S. Kamachi, and S. Asano. 1997. Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: inverse correlation between the half-life and bone marrow myeloid cell pool. Int. J. Hematol. 66:57-67.
19. Wilson, A., P. Corthesy, P. Reichenbach, H. R. MacDonald, and M. Nabholz. 1994. Interleukin (IL)-1 and IL-2 receptor alpha and beta expression in immature thymocytes. Eur. J. Immunol. 24:1729-1735.
20. Yamaoka, K., T. Nakagawa, and T. Uno. 1978. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6:547-558.